No abstract

No abstract

No abstract

were reviewed. Inclusion criteria was eligibility for hepatic resection. Patients not eligible for hepatic resection were excluded. Results were expressed as frequencies and median values. Results: Nine patients patients were included. Five (55%) were female gendered and the median age was 62 years old. Primary tumor was located mainly at rectum and sigmoid (66%) and the majority of cases had synchronic liver metastases (88%), previous emergency surgery for obstructed colonic cancer (66%) and were on different regimens of palliative chemotherapy (100%). Unilobar liver metastases were found in 77%. Hepatic resection consisted of nodulectomy (3e34%), sectorectomy (3e34%), bisegmentectomy (2e21%) and right hepatectomy (1e11%). Margins were R0 (8e90%) and R1 (1e10%). Seven patients were tested for K-ras mutation and 4e57% resulted positive. Estimated disease free survival was 7 months and median global survival 25 months. Conclusions: Palliative colonic resection and chemotherapy is a therapeutic option for patients with obstructive stage IV colorectal cancer. Liver resection in this population may warrant survival benefit.

No abstract